In vivo functional differences in microvascular response of 4T1 and Caki-1 tumors after treatment with OXi4503
about
In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Limitations of the dorsal skinfold window chamber model in evaluating anti-angiogenic therapy during early phase of angiogenesisThe unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerSerial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent.Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling.
P2860
Q33738607-388E0329-59A2-47F4-9C45-1395E2548E97Q34008504-6F18FB2F-E8F9-46C9-9186-C3480A904A49Q34122191-810C917E-B80A-45DC-9333-1B6C33730690Q34478450-6BF6932B-13A3-41A0-B465-1A1BECBBFFE0Q34491366-D6F82FFA-157E-4B70-A351-DA9C73AEC3C4Q34538659-5FCF064C-7B6A-4848-BFF7-E046A42AA9A3Q36225973-9FFE6E91-C05A-4F58-BB81-872A7A17F719Q37174704-3FF41027-2DF6-40A7-B627-E996A4814F1D
P2860
In vivo functional differences in microvascular response of 4T1 and Caki-1 tumors after treatment with OXi4503
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo functional differences ...... s after treatment with OXi4503
@ast
In vivo functional differences ...... s after treatment with OXi4503
@en
In vivo functional differences ...... s after treatment with OXi4503
@nl
type
label
In vivo functional differences ...... s after treatment with OXi4503
@ast
In vivo functional differences ...... s after treatment with OXi4503
@en
In vivo functional differences ...... s after treatment with OXi4503
@nl
prefLabel
In vivo functional differences ...... s after treatment with OXi4503
@ast
In vivo functional differences ...... s after treatment with OXi4503
@en
In vivo functional differences ...... s after treatment with OXi4503
@nl
P2093
P2860
P1433
P1476
In vivo functional differences ...... s after treatment with OXi4503
@en
P2093
Brian S Sorg
Casey Dedeugd
Dietmar W Siemann
Mamta Wankhede
P2860
P304
P577
2010-03-01T00:00:00Z